TomoSeq data search

Data search

Results for MligTC455_41204

Cluster

Total UMI counts

Global CPM

Transcripts

Categories

Human homolog

Annotation

MligTC455_41204

27

0.57

Mlig455_001961

Neo: -

Age: -

B4GALT2

Mlig455_001961 {REF} {Length: 1967} {Pfam: N-terminal region of glycosyl transferase group 7 [PF13733.8, score=128.6]; N-terminal domain of galactosyltransferase [PF02709.16, score=95.8]} {Human: ENSG00000117411, B4GALT2, beta-1,4-galactosyltransferase 2, [Score=215, Expect=6e-68]; ENSG00000121578, B4GALT4, beta-1,4-galactosyltransferase 4, [Score=211, Expect=1e-66]; ENSG00000086062, B4GALT1, beta-1,4-galactosyltransferase 1, [Score=210, Expect=1e-65]; ENSG00000158470, B4GALT5, beta-1,4-galactosyltransferase 5, [Score=207, Expect=1e-64]; ENSG00000118276, B4GALT6, beta-1,4-galactosyltransferase 6, [Score=205, Expect=1e-64]; ENSG00000158850, B4GALT3, beta-1,4-galactosyltransferase 3, [Score=205, Expect=8e-64]} {Mouse: ENSMUSG00000028541, B4galt2, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2, [Score=215, Expect=4e-68]; ENSMUSG00000028413, B4galt1, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, [Score=215, Expect=9e-68]; ENSMUSG00000017929, B4galt5, UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5, [Score=209, Expect=9e-66]; ENSMUSG00000056124, B4galt6, UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6, [Score=206, Expect=1e-64]; ENSMUSG00000052423, B4galt3, UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3, [Score=205, Expect=7e-64]} {Dmel: FBgn0027538, beta4GalNAcTA, [Score=203, Expect=3e-63]} {Celegans: WBGene00000269, bre-4, Beta-1,4-N-acetylgalactosaminyltransferase bre-4, [Score=222, Expect=4e-71]} {Smed: dd_Smed_v6_13813_0_1, dd_Smed_v6_13813_0_1, [RH, Score=240, Expect=8e-79]} {RNA1310_30379} {RNA815_40748}

Cumulative graph for MligTC455_41204

Region-enriched expression

Region	logFC	logCPM	Pvalue	FDR	Specificity
RegionR1	-0.03	0.954	0.99962	1.00000
RegionR2	0.134	0.954	0.99816	1.00000
RegionR3	1.094	0.954	0.90966	1.00000
RegionR4	1.154	0.954	0.33060	0.64886
RegionR5	-1.029	0.954	1.00000	1.00000
RegionR6	0.707	0.954	0.85723	1.00000
RegionR7	-1.746	0.954	1.00000	1.00000
RegionR8	-0.284	0.954	0.99977	1.00000

Regeneration-enriched expression

Region	logFC	logCPM	PValue	FDR	Specificity
RegenerationR1	-2.737	0.954	1.00000	1.00000
RegenerationR2	0.027	0.954	0.84541	1.00000
RegenerationR3	-1.26	0.954	0.49219	0.85487
RegenerationR4	-1.843	0.954	0.49693	0.86748
RegenerationR5	1.22	0.954	0.74397	0.97002
RegenerationR6	-2.021	0.954	0.38915	0.72919
RegenerationBL	0.714	0.954	0.80990	1.00000
RegenerationTP	-1.723	0.954	0.99959	1.00000

Genes with expression patterns similar to MligTC455_41204

Nr.	Cluster	Total UMI counts	Global CPM	Transcripts	Categories	Human homolog	Σ Spearman correlations	Int1	Int2	Int3	Reg1	Reg2	Reg3	Annotation
1.	MligTC455_41204	27	0.57	Mlig455_001961	Neo: - Age: -	B4GALT2	3	-	-	1.000	-	1.000	1.000	Mlig455_001961 {REF} {Length: 1967} {Pfam: N-terminal region of glycosyl transferase group 7 [PF13733.8, score=128.6]; N-terminal domain of galactosyltransferase [PF02709.16, score=95.8]} {Human: ENSG00000117411, B4GALT2, beta-1,4-galactosyltransferase 2, [Score=215, Expect=6e-68]; ENSG00000121578, B4GALT4, beta-1,4-galactosyltransferase 4, [Score=211, Expect=1e-66]; ENSG00000086062, B4GALT1, beta-1,4-galactosyltransferase 1, [Score=210, Expect=1e-65]; ENSG00000158470, B4GALT5, beta-1,4-galactosyltransferase 5, [Score=207, Expect=1e-64]; ENSG00000118276, B4GALT6, beta-1,4-galactosyltransferase 6, [Score=205, Expect=1e-64]; ENSG00000158850, B4GALT3, beta-1,4-galactosyltransferase 3, [Score=205, Expect=8e-64]} {Mouse: ENSMUSG00000028541, B4galt2, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2, [Score=215, Expect=4e-68]; ENSMUSG00000028413, B4galt1, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, [Score=215, Expect=9e-68]; ENSMUSG00000017929, B4galt5, UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5, [Score=209, Expect=9e-66]; ENSMUSG00000056124, B4galt6, UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6, [Score=206, Expect=1e-64]; ENSMUSG00000052423, B4galt3, UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3, [Score=205, Expect=7e-64]} {Dmel: FBgn0027538, beta4GalNAcTA, [Score=203, Expect=3e-63]} {Celegans: WBGene00000269, bre-4, Beta-1,4-N-acetylgalactosaminyltransferase bre-4, [Score=222, Expect=4e-71]} {Smed: dd_Smed_v6_13813_0_1, dd_Smed_v6_13813_0_1, [RH, Score=240, Expect=8e-79]} {RNA1310_30379} {RNA815_40748}
2.	MligTC455_14363	57	1.18	Mlig455_014133	Neo: - Age: - Region-enriched R2: 4.499/0.01811		1.847	-	-	0.977	-	0.870	-	Mlig455_014133 {REF} {Length: 323} {NoTransDecoderORF}
3.	MligTC455_14308	56	1.17	Mlig455_058785	Neo: - Age: -	CNBD2	1.845	-	-	0.868	-	0.977	-	Mlig455_058785 {REF} {Length: 2153} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=56.0]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=69.7, Expect=7e-12]} {Mouse: ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=71.2, Expect=9e-13]} {Dmel: FBgn0085421, Epac, Exchange protein directly activated by cAMP, [Score=54.7, Expect=2e-07]} {RNA1310_32252} {RNA815_58357}
4.	MligTC455_46161	97	2.03	Mlig455_007908	Neo: - Age: -		1.817	-	-	0.855	-	0.962	-	Mlig455_007908 {REF} {Length: 1544} {RNA1509_43120} {RNA1310_22234} {RNA815_35898}
5.	MligTC455_48303	18	0.38	Mlig455_031492	Neo: - Age: -		1.695	-	-	0.956	-	-	0.739	Mlig455_031492 {REF} {Length: 1256} {RNA1310_110499} {RNA815_61754}
6.	MligTC455_50311	51	1.07	Mlig455_045965	Neo: - Age: Up-Down-Down		0.973	-	-	0.973	-	-	-	Mlig455_045965 {REF} {Length: 1555} {RNA1509_53928} {RNA1310_9320.1, RNA1509_53928} {RNA1509_53928, RNA815_16905}
7.	MligTC455_26692	25	0.52	Mlig455_055566	Neo: - Age: Down-Up-Down	PDE9A	0.967	-	-	-	-	0.967	-	Mlig455_055566 {REF} {Length: 2898} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=286.2]} {Human: ENSG00000160191, PDE9A, phosphodiesterase 9A, [RH, Score=604, Expect=0.0]} {Mouse: ENSMUSG00000041119, Pde9a, phosphodiesterase 9A, [RH, Score=604, Expect=0.0]} {Dmel: FBgn0259171, Pde9, Phosphodiesterase 9, [RH, Score=354, Expect=1e-108]} {Celegans: WBGene00020114, pde-4, Probable 3',5'-cyclic phosphodiesterase pde-4, [Score=184, Expect=2e-51]} {Smed: dd_Smed_v6_13304_0_1, dd_Smed_v6_13304_0_1, [RH, Score=328, Expect=7e-106]} {RNA1310_14017} {RNA815_23817}
8.	MligTC455_42136	34	0.7	Mlig455_024685, Mlig455_024710, Mlig455_044068	Neo: - Age: -		0.963	-	-	-	-	0.963	-	Mlig455_024685 {REF} {Length: 3505} {Pfam: Peptidase family M13 [PF05649.15, score=22.4]} {RNA1310_55586} {RNA815_38189} Mlig455_024710 {REF} {Length: 3484} {RNA1310_55586} {RNA815_38189} Mlig455_044068 {REF} {Length: 2578} {Pfam: Peptidase family M13 [PF05649.15, score=26.4]}
9.	MligTC455_37152	32	0.66	Mlig455_060572	Neo: - Age: -	CLCA1	0.962	-	-	0.962	-	-	-	Mlig455_060572 {REF} {Length: 6370} {Pfam: Calcium-activated chloride channel N terminal [PF08434.13, score=90.7]; von Willebrand factor type A domain [PF00092.30, score=61.8]; von Willebrand factor type A domain [PF13519.8, score=53.2]; von Willebrand factor type A domain [PF13768.8, score=49.1]} {Human: ENSG00000016490, CLCA1, chloride channel accessory 1, [Score=224, Expect=2e-60]} {Mouse: ENSMUSG00000028255, Clca1, chloride channel accessory 1, [Score=212, Expect=2e-56]} {Smed: dd_Smed_v6_696_0_1, dd_Smed_v6_696_0_1, [RH, Score=135, Expect=1e-32]} {RNA1509_55009} {RNA1310_8014.1, RNA1509_55009} {RNA1509_55009, RNA815_22781}
10.	MligTC455_38929	45	0.93	Mlig455_046982	Neo: - Age: -		0.962	-	-	-	-	0.962	-	Mlig455_046982 {REF} {Length: 862} {NoTransDecoderORF} {RNA1509_23064} {RNA1310_9108} {RNA815_5569}
11.	MligTC455_42240	80	1.66	Mlig455_038267	Neo: - Age: Down-Up-Down		0.962	-	-	-	-	0.962	-	Mlig455_038267 {REF} {Length: 989} {RNA1310_36501} {RNA815_32545}
12.	MligTC455_17479	32	0.66	Mlig455_032081, Mlig455_070278	Neo: - Age: logFC(26M/2M)=-0.516	CHRNA3	0.961	-	-	-	-	0.961	-	Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960}
13.	MligTC455_36838	55	1.15	Mlig455_023457	Neo: - Age: -	SSTR4	0.958	-	-	-	-	0.958	-	Mlig455_023457 {REF} {Length: 5737} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=97.3]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=60.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=20.5]} {Human: ENSG00000132671, SSTR4, somatostatin receptor 4, [Score=48.5, Expect=1e-05]} {Mouse: ENSMUSG00000031489, Adrb3, adrenergic receptor, beta 3, [Score=53.1, Expect=3e-07]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=52.0, Expect=9e-07]} {Dmel: FBgn0029768, SPR, Sex peptide receptor, [RH, Score=154, Expect=9e-42]} {Celegans: WBGene00009629, sprr-2, Sex Peptide Receptor (Drosophila) Related, [RH, Score=144, Expect=3e-38]} {Smed: dd_Smed_v6_14444_0_1, dd_Smed_v6_14444_0_1, [RH, Score=192, Expect=3e-56]} {RNA1310_22470} {RNA815_32139}
14.	MligTC455_45840	188	3.91	Mlig455_045494	Neo: - Age: -	METTL18	0.957	-	-	-	-	0.957	-	Mlig455_045494 {REF} {Length: 1926} {TRANSSPLICED} {Pfam: Lysine methyltransferase [PF10294.11, score=46.2]; Methyltransferase domain [PF13649.8, score=24.5]; Methyltransferase domain [PF13489.8, score=23.7]; Methyltransferase domain [PF08242.14, score=21.7]} {Human: ENSG00000171806, METTL18, methyltransferase like 18, [RH, Score=135, Expect=2e-36]} {Mouse: ENSMUSG00000041396, Mettl18, methyltransferase like 18, [RH, Score=132, Expect=1e-35]} {Dmel: FBgn0031494, CG17219, [RH, Score=145, Expect=3e-41]} {Celegans: WBGene00010450, K01A11.2, [RH, Score=139, Expect=7e-40]} {Smed: dd_Smed_v6_15403_0_1, dd_Smed_v6_15403_0_1, [RH, Score=140, Expect=8e-40]} {RNA1509_54994} {RNA1310_33986} {RNA815_20017}
15.	MligTC455_10029	31	0.65	Mlig455_034776	Neo: - Age: -	FCN3	0.955	-	-	0.955	-	-	-	Mlig455_034776 {REF} {Length: 1488} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=116.8]} {Human: ENSG00000142748, FCN3, ficolin 3, [Score=98.2, Expect=4e-23]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=92.8, Expect=2e-20]; ENSMUSG00000026938, Fcna, ficolin A, [Score=88.2, Expect=2e-19]} {Dmel: FBgn0051832, CG31832, [Score=82.0, Expect=5e-18]} {Celegans: WBGene00020516, T15B7.1, [Score=59.3, Expect=8e-10]}
16.	MligTC455_24273	48	1.01	Mlig455_005193	Neo: - Age: -	AC254952.1	0.955	-	-	0.955	-	-	-	Mlig455_005193 {REF} {Length: 1491} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=92.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=64.9]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=124, Expect=2e-30]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=122, Expect=8e-30]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=122, Expect=8e-30]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=124, Expect=1e-30]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=123, Expect=2e-30]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=115, Expect=1e-27]} {Celegans: WBGene00017580, lgc-4, Ligand-gated ion channel 4, [Score=117, Expect=2e-28]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=114, Expect=2e-27]} {RNA1509_43533} {RNA1310_21349.2} {RNA815_39337}
17.	MligTC455_32667	146	3.04	Mlig455_017033	Neo: - Age: logFC(26M/2M)=-0.866 Region-enriched R4: 3.443/0.03979		0.954	-	-	0.954	-	-	-	Mlig455_017033 {REF} {Length: 9517} {Pfam: REJ domain [PF02010.17, score=66.2]} {RNA1509_21224} {RNA1310_402.1} {RNA815_93.1}
18.	MligTC455_42165	11	0.24	Mlig455_065602	Neo: - Age: - Region-enriched R2: 9.816/0.00009		0.951	-	-	-	-	0.951	-	Mlig455_065602 {REF} {Length: 634} {Pfam: Globin [PF00042.24, score=32.5]} {RNA1310_147077} {RNA815_18392}

Berezikov Lab - 2020-2021 © ERIBA